SCHEMBL21392853

SCHEMBL21392853

C=CC(=O)N(CC)Cc1ccoc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.52
ALOX5 P09917 1/20 0.46
LMNA P02545 1/20 0.38
PSMB5 P28074 3/20 0.38
HCAR3 P49019 1/20 0.37
CETP P11597 1/20 0.36
F2 P00734 3/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
ALDH1A1 P00352 3/20 0.34
FAAH O00519 2/20 0.34
CNR2 P34972 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28226951 0.81 TRPM8 (0.57) TRPM8ALOX5LMNAHCAR3CETP
SCHEMBL28226280 0.80 TRPM8 (0.67) TRPM8ALOX5LMNAHCAR3CETP
SCHEMBL286790 0.78 LMNA (0.64) TRPM8LMNAALDH1A1TDP1
SCHEMBL2719625 0.77 TRPM8 (0.60) TRPM8ALOX5ALDH1A1MAPTKMT2A
SCHEMBL2719629 0.77 TRPM8 (0.60) TRPM8ALOX5ALDH1A1MAPTKMT2A
SCHEMBL7317141 0.75 USP2 (0.54) LMNAFNTAFNTBALDH1A1MEN1
SCHEMBL15806971 0.74 TRPM8 (0.43) TRPM8ALOX5HCAR3F2ALDH1A1
SCHEMBL8281435 0.73 BCL2A1 (0.58) LMNAALDH1A1MEN1KMT2ATDP1
SCHEMBL10547278 0.72 TRPM8 (0.49) TRPM8ALOX5LMNAHCAR3F2
SCHEMBL25554955 0.72 ALDH1A1 (0.61) TRPM8ALOX5LMNAHCAR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 TRPM8 4071/4885ALOX5 3704/4885LMNA 1016/4885
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES RNF114, RNF4, RNF168 TRPM8 4851/4885ALOX5 4759/4885LMNA 3321/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 TRPM8 4071/4885ALOX5 3704/4885LMNA 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.